{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:33:42Z","timestamp":1792794822307,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grant-in-Aid for Progressive Renal Disease Research from the Ministry of Health, Labour and Welfare of Japan"},{"name":"Okinaka Memorial Institute for Medical Research, Toranomon Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1067-2","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T03:29:11Z","timestamp":1539919751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cyst infection in autosomal dominant polycystic kidney disease: penetration of meropenem into infected cysts"],"prefix":"10.1186","volume":"19","author":[{"given":"Satoshi","family":"Hamanoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0825-2512","authenticated-orcid":false,"given":"Tatsuya","family":"Suwabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Hazue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Mise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenmei","family":"Takaichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,19]]},"reference":[{"issue":"14","key":"1067_CR1","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med. 2008;359(14):1477\u201385.","journal-title":"N Engl J Med"},{"issue":"9569","key":"1067_CR2","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007;369(9569):1287\u2013301.","journal-title":"Lancet"},{"issue":"7","key":"1067_CR3","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2215\/CJN.01870309","volume":"4","author":"M Sallee","year":"2009","unstructured":"Sallee M, Rafat C, Zahar JR, Paulmier B, Grunfeld JP, Knebelmann B, Fakhouri F. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009;4(7):1183\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"1067_CR4","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s10096-015-2361-6","volume":"34","author":"T Suwabe","year":"2015","unstructured":"Suwabe T, Araoka H, Ubara Y, Kikuchi K, Hazue R, Mise K, Hamanoue S, Ueno T, Sumida K, Hayami N, et al. Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics. Eur J Clin Microbiol Infect Dis. 2015;34(7):1369\u201379.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"1067_CR5","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrneph.2017.127","volume":"13","author":"MB Lanktree","year":"2017","unstructured":"Lanktree MB, Chapman AB. New treatment paradigms for ADPKD: moving towards precision medicine. Nat Rev Nephrol. 2017;13(12):750\u201368.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"1067_CR6","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s10157-012-0650-2","volume":"16","author":"T Suwabe","year":"2012","unstructured":"Suwabe T, Ubara Y, Sumida K, Hayami N, Hiramatsu R, Yamanouchi M, Hasegawa E, Hoshino J, Sawa N, Saitoh S, et al. Clinical features of cyst infection and hemorrhage in ADPKD: new diagnostic criteria. Clin Exp Nephrol. 2012;16(6):892\u2013902.","journal-title":"Clin Exp Nephrol"},{"key":"1067_CR7","volume-title":"GeneReviews\u00ae[Internet]","author":"PC Harris","year":"2015","unstructured":"Harris PC, Torres VE. Polycystic kidney disease, Autosomal Dominant. In: Adam MP, editor. GeneReviews\u00ae[Internet]. Seattle: University of Washington; 2015."},{"key":"1067_CR8","unstructured":"Matsumoto K, Hashimoto K, Nakamura Y, Morita K: Stability of a carbapenem antibiotic, meropenem, in blood sample. Bulletin of Institute for Interdisciplinary Studies of Culture Doshisha Women\u2019s College of Liberal Arts 2017, 34:180\u2013183."},{"issue":"2","key":"1067_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/AAC.37.2.229","volume":"37","author":"M Chimata","year":"1993","unstructured":"Chimata M, Nagase M, Suzuki Y, Shimomura M, Kakuta S. Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease. Antimicrob Agents Chemother. 1993;37(2):229\u201333.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"1067_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1128\/AAC.36.7.1532","volume":"36","author":"BA Christensson","year":"1992","unstructured":"Christensson BA, Nilsson-Ehle I, Hutchison M, Haworth SJ, Oqvist B, Norrby SR. Pharmacokinetics of meropenem in subjects with various degrees of renal impairment. Antimicrob Agents Chemother. 1992;36(7):1532\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"1067_CR11","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1128\/AAC.36.12.2794","volume":"36","author":"A Leroy","year":"1992","unstructured":"Leroy A, Fillastre JP, Borsa-Lebas F, Etienne I, Humbert G. Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects and in patients with renal impairment. Antimicrob Agents Chemother. 1992;36(12):2794\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1067_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/BF00314864","volume":"42","author":"A Leroy","year":"1992","unstructured":"Leroy A, Fillastre JP, Etienne I, Borsa-Lebas F, Humbert G. Pharmacokinetics of meropenem in subjects with renal insufficiency. Eur J Clin Pharmacol. 1992;42(5):535\u20138.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1067_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2165\/00003088-200039040-00003","volume":"39","author":"F Thalhammer","year":"2000","unstructured":"Thalhammer F, Horl WH. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy. Clin Pharmacokinet. 2000;39(4):271\u20139.","journal-title":"Clin Pharmacokinet"},{"key":"1067_CR14","unstructured":"Yamaguchi K, Ishii Y, Tateda K, Iwata M, Watanabe N, Shinagawa M, Kayaba H, Kimura M, Suwabe A, Kaku M et al: [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2012]. Jpn J Antibiot 2014, 67(2):73\u2013107."},{"issue":"1\u20132","key":"1067_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0732-8893(95)00053-D","volume":"22","author":"WA Craig","year":"1995","unstructured":"Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis. 1995;22(1\u20132):89\u201396.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"1067_CR16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/infdis\/158.4.831","volume":"158","author":"B Vogelman","year":"1988","unstructured":"Vogelman B, Gudmundsson S, Leggett J, Turnidge J, Ebert S, Craig WA. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis. 1988;158(4):831\u201347.","journal-title":"J Infect Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1067-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1067-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1067-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T19:18:46Z","timestamp":1571426326000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1067-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,19]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1067-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,19]]},"assertion":[{"value":"28 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This prospective observational study was reviewed and approved by the ethics committee of Toranomon Hospital in July 2013. This study was registered with the University Hospital Medical Information Network (UMIN) as \u201cPenetration of meropenem into cysts in patients with autosomal dominant polycystic kidney disease (ADPKD)\u201d, UMIN ID 000011292. All patients fitting gave written consent after being fully informed about this study. The study protocol conformed to the provisions of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent to publish clinical information at the onset of cyst infection was obtained from study participants. Written consent forms are stored in Department of Nephrology, Toranomon Hospital and can be requested at any time.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"272"}}